Professor Matthew Porteus

Presentation: Gene Doping – Should we be worried in 2032?

Professor Matthew Porteus, Stanford University and WADA Gene and Cell Doping Expert Advisory Group

After completing a degree in ‘History and Science’ at Harvard University, Matt completed his PhD at Stanford Medical School with his PhD focused on understanding the molecular basis of mammalian forebrain development. Matt did his post-doctoral research where he worked with Dr. David Baltimore at MIT and CalTech on studies in developing homologous recombination as a strategy to correct disease causing mutations in stem cells as definitive and curative therapy for children with genetic diseases of the blood, particularly sickle cell disease. Matt’s work has been the first to demonstrate that gene correction could be achieved in human cells at frequencies that were high enough to potentially cure patients and he is considered one of the pioneers and founders of the field of genome editing—a field that now encompasses thousands of labs and several new companies throughout the world.